tiprankstipranks
Advertisement
Advertisement

SLXN Stock Latest News

Silexion Therapeutics announces 1-for-10 reverse share split
The FlySilexion Therapeutics announces 1-for-10 reverse share split
15h ago
SLXN
Silexion Therapeutics Announces Reverse Split to Maintain Listing
PremiumCompany Announcements
Silexion Therapeutics Announces Reverse Split to Maintain Listing
16h ago
8K
SLXN
3 Penny Stocks to Watch Now, 5/21/26
PremiumMarket News
3 Penny Stocks to Watch Now, 5/21/26
5d ago
HCWB
MTVA
Silexion Therapeutics Announces Warrant Inducement Financing Agreement
PremiumCompany Announcements
Silexion Therapeutics Announces Warrant Inducement Financing Agreement
11d ago
8K
SLXN
Silexion Announces Positive Preclinical Data for SIL204 Therapy
PremiumCompany Announcements
Silexion Announces Positive Preclinical Data for SIL204 Therapy
12d ago
8K
SLXN
Silexion Therapeutics initiates GMP clinical batch manufacturing of SIL204
PremiumThe FlySilexion Therapeutics initiates GMP clinical batch manufacturing of SIL204
14d ago
SLXN
Silexion Advances SIL204 With Manufacturing and Trial Approval
Premium
Company Announcements
Silexion Advances SIL204 With Manufacturing and Trial Approval
14d ago
8K
SLXN
Silexion Therapeutics Shareholders Approve Capital Increase, Reverse Split
Premium
Company Announcements
Silexion Therapeutics Shareholders Approve Capital Increase, Reverse Split
21d ago
8K
SLXN
Silexion Therapeutics submits SIL204 clinical trial application to Germany
PremiumThe Fly
Silexion Therapeutics submits SIL204 clinical trial application to Germany
29d ago
SLXN
Silexion advances SIL204 to EU Phase 2/3 pancreatic trial
PremiumCompany Announcements
Silexion advances SIL204 to EU Phase 2/3 pancreatic trial
29d ago
8K
SLXN
Silexion Therapeutics Announces Immediate Board Membership Change
PremiumCompany Announcements
Silexion Therapeutics Announces Immediate Board Membership Change
2M ago
8K
SLXN
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204
PremiumThe Fly
Silexion Therapeutics approved to initiate Phase 2/3 clinical trial of SIL204
2M ago
SLXN
Silexion gains approval for SIL204 pancreatic cancer trial
PremiumCompany AnnouncementsSilexion gains approval for SIL204 pancreatic cancer trial
2M ago
8K
SLXN
Silexion Shareholders Reject Capital Increase and Plan Amendments
Premium
Company Announcements
Silexion Shareholders Reject Capital Increase and Plan Amendments
2M ago
8K
SLXN
Silexion Therapeutics urges shareholders to vote ahead of EGM
Premium
The Fly
Silexion Therapeutics urges shareholders to vote ahead of EGM
3M ago
SLXN
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
PremiumTipRanks Newswire
Silexion Therapeutics is developing a potential “holy grail” play in precision oncology (NASDAQ: SLXN)
3M ago
SLXN
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
PremiumCompany Announcements
Silexion Highlights SIL204 RNAi Pancreatic Cancer Program Progress
4M ago
8K
SLXN
Silexion outlines 2026 plans after transformational 2025 progress
PremiumCompany Announcements
Silexion outlines 2026 plans after transformational 2025 progress
5M ago
8K
SLXN
Silexion Therapeutics issues letter to shareholders
PremiumThe Fly
Silexion Therapeutics issues letter to shareholders
5M ago
SLXN
Silexion Therapeutics Submits Phase 2/3 Trial Application
PremiumCompany AnnouncementsSilexion Therapeutics Submits Phase 2/3 Trial Application
5M ago
8K
SLXN
Silexion submits Phase 2/3 trial application to Israel for SIL204
Premium
The Fly
Silexion submits Phase 2/3 trial application to Israel for SIL204
5M ago
SLXN
Silexion Therapeutics initiated with a Buy at Litchfield Hills
Premium
The Fly
Silexion Therapeutics initiated with a Buy at Litchfield Hills
5M ago
SLXN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >